Gibson Dunn Reps Accuray In $277M Radiotherapy Deal
California radiation oncology company Accuray on Monday announced plans to buy TomoTherapy Inc. for $277 million, creating a new global cancer treatment provider expected to pull in annual revenue of more...To view the full article, register now.
Already a subscriber? Click here to view full article